← Back to Search
Lipophilic Peptide Character - What Oral Barriers Fear The Most.
O. Zupančič, A. Bernkop-Schnürch
Published 2017 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
Peptide therapeutics is currently one of the fastest growing markets worldwide and consequently convenient ways of administration for these drugs are highly on demand. In particular, oral dosage forms would be preferred. A relative large molecular weight and high hydrophilicity, however, result in comparatively very low oral bioavailability being in most cases below 1%. Lipid based formulations (LBF), in particular self-emulsifying drug delivery systems (SEDDS) and solid lipid nanoparticles (SLN) as well as liposomes are among the most promising tools for oral peptide delivery. Key to success in orally delivering peptides via LBF seems to be a sufficiently high lipophilic character of those therapeutic agents. Hence, different non-covalent and covalent peptide lipidization methods from drug delivery point of view are presented. On the one hand, among non-covalent lipidization methods hydrophobic ion pairing seems to be a promising way to sufficiently increase peptide lipophilicity providing high drug payloads in the lipid phase, a protective effect against presystemic metabolism via thiol-disulphide exchange reactions and proteolysis as well as an improved intestinal membrane permeability. On the other hand, covalent methods like conjugating fatty acids via amidation, esterification, reversible aqueous lipidization (REAL) and cyclization also show potential. The present review therefore describes those lipidization methods in detail and critically evaluates their contribution in successfully overcoming the oral barriers.
This paper references
Hypoglycemic activity and stability enhancement of human insulin–tat mixture loaded in elastic anionic niosomes
A. Manosroi (2016)
One-pot aqueous synthesis of cysteine-capped CdTe/CdS core–shell nanowires
Y. Shan (2014)
Identification of histatins as tannin-binding proteins in human saliva.
Q. Yan (1995)
Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
R. Nelson (2009)
Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.
Saeid Moghassemi (2015)
Interaction of tannin with human salivary proline-rich proteins.
Y. Lu (1998)
A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation
Ashaben Patel (2014)
A palmitoyl conjugate of insect pentapeptide Yamamarin arrests cell proliferation and respiration
Y. Sato (2010)
Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems.
P. Li (2013)
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
K. Witt (2001)
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex.
S. K. Kim (2010)
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
Amide bond formation and peptide coupling
C. Montalbetti (2005)
Angiotensin analogues palmitoylated in positions 1 and 4.
L. Maletínská (1997)
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1‐DD/ISCOM
N. Lycke (2004)
Preparation and properties of buserelin suspensions.
F. Ryszka (1994)
Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
P. Li (2014)
Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs.
J. Wang (2015)
Esterase-Sensitive Cyclic Prodrugs of Peptides: Evaluation of an Acyloxyalkoxy Promoiety in a Model Hexapeptide
G. Pauletti (2004)
Synthesis and antinociceptive activity of orally active opioid peptides: improvement of oral bioavailability by esterification.
T. Ogawa (2003)
Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing
M. Powers (1993)
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
POLYMER MICELLE INTERACTIONS - PHYSICAL ORGANIC ASPECTS
J. Brackman (1993)
Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
T. Rezai (2006)
Macrolactonizations in the total synthesis of natural products.
A. Parenty (2006)
Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles
Ripal Gaudana (2011)
Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model.
U. Gietz (1998)
Evaluation of pharmacological efficacy of 'insulin-surfoplex' encapsulated polymer vesicles.
R. Rastogi (2009)
Storage Stability of Bivalirudin: Hydrophilic Versus Lipophilic Solutions.
O. Zupančič (2017)
Lipophilization of somatostatin analog RC‐160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro
P. Dasgupta (2000)
Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.
W. Chen (2008)
Solution Structures of i to i + 3 Cyclized Model Peptides: Building Blocks Mimicking Specific Conformations
H. R. Marepalli (1996)
Pre-systemic metabolism of orally administered drugs and strategies to overcome it.
I. Pereira de Sousa (2014)
The role of decorated SDS micelles in sub-CMC protein denaturation and association.
K. Andersen (2009)
Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery
G. Leonavičiūtė (2015)
Bringing macrocycles full circle
Joanne D Kotz (2012)
Synthesis, characterization and in vivo activity of salmon calcitonin coconjugated with lipid and polyethylene glycol.
W. Cheng (2009)
Hydrophobic Ion Pairing: Altering the Solubility Properties of Biomolecules
J. D. Meyer (2004)
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Hong Yuan (2009)
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.
Michael J. Hackett (2013)
The use of multifunctional polymers for non-invasive peptide and protein application
A. Bernkop-Schnürch (2000)
Delivery of Therapeutic Proteins: Challenges and Strategies.
K. Rehman (2016)
Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.
E. Moroz (2016)
Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
T. Fan (2014)
Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery.
Y. Onuki (2004)
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
L. Guo (2011)
Pulsatile and sustained peptides release from Zn(II) suspensions.
F. Ryszka (2003)
Aqueous-Soluble, Non-Reversible Lipid Conjugate of Salmon Calcitonin: Synthesis, Characterization and In Vivo Activity
W. Cheng (2006)
Formulation of sustained release aqueous Zn-hirudin suspensions.
U. Gietz (2000)
Reversible lipidization for the oral delivery of leu-enkephalin
J. Wang (2006)
Stability of Various Liposome Formulation Containing the Phytochemical-Peptide Derivatives
Byung Seok Han (2016)
Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery
O. Zupančič (2017)
Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin.
O. Zupančič (2016)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (2001)
Contemporary strategies for peptide macrocyclization.
C. J. White (2011)
Optical properties of isolated hormone oxytocin dianions: ionization, reduction, and copper complexation effects.
L. Joly (2009)
Precipitation of egg white proteins below their isoelectric points by sodium dodecyl sulphate and temperature.
P. O. Hegg (1979)
Formulation and Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides
P. Constantinides (2004)
Lipophilicity--methods of determination and its role in medicinal chemistry.
Ewelina E Rutkowska (2013)
Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.
S. Gazal (2002)
Synthesis, characterization, and application of iodoacetamide derivatives utilized for the ALiPHAT strategy.
D. Williams (2008)
Applications of the Ion-Pair Concept to Hydrophilic Substances with Special Emphasis on Peptides
D. Quintanar-Guerrero (2004)
Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs
Hongwu Sun (2012)
Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol.
C. Loguercio (1991)
Stability of Acyl Derivatives of Insulin in the Small Intestine: Relative Importance of Insulin Association Characteristics in Aqueous Solution
Hiroyuki Asada (2004)
Structure and stability of insulin dissolved in 1-octanol
J. Matsuura (1993)
Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
J. Griesser (2017)
LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides.
Zhihua Yang (2007)
CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen1
A. Mowat (2001)
Nanotechnology solutions for mucosal immunization.
S. Chadwick (2010)
Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.
P. C. Christophersen (2013)
Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
R. Orlowski (1987)
Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor
H. Li (2005)
Mucoadhesive vs. mucopenetrating particulate drug delivery.
Kesinee Netsomboon (2016)
Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
O. Zupančič (2016)
Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
Yuefeng Wang (2003)
Phenylpropionic Acid-Based Cyclic Prodrugs of Opioid Peptides that Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeation
O. S. Gudmundsson (2004)
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs.
Liyun Yuan (2008)
Oxytocin-receptor binding: why divalent metals are essential.
Dengfeng Liu (2005)
Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex
Jinjie Zhang (2011)
Solid lipid nanoparticles modified with stearic acid–octaarginine for oral administration of insulin
Z. Zhang (2012)
Preparation and properties of selected Zn(II)-peptide complexes in suspension.
B. Dolińska (2003)
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
A. H. Kahns (2004)
Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
Mao-Bo Cheng (2008)
Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin
M. Karsdal (2008)
Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Shunwen Hu (2013)
Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release
R. Mahjub (2015)
Surfactant interactions with biomembranes and proteins
M. Jones (1992)
Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles.
H. Yoo (2001)
Peptide therapeutics: current status and future directions.
K. Fosgerau (2015)
Converting peptides into drug leads by lipidation.
L. Zhang (2012)
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
Absorption Enhancers: Applications and Advances
B. Aungst (2011)
Characterisation of the thiol–disulphide chemistry of desmopressin by LC, μ-LC, LC-ESI-MS and Maldi-Tof
T. Schmitz (2005)
Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.
Chunhui Chen (2013)
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery.
S. Maher (2012)
In vitro and in vivo evaluation of a novel oral insulin formulation
Er-li Ma (2006)
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study.
S. V. R. Rao (2008)
Preparation, Purification, and Characterization of a Reversibly Lipidized Desmopressin with Potentiated Anti-Diuretic Activity
J. Wang (2004)
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems.
T. Karamanidou (2015)
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
M. Afargan (2001)
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
J. Parmentier (2010)
Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.
C. Mcmartin (1987)
Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide.
R. Yang (2010)
Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery
A. Mahmood (2016)
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
G. Fricker (2010)
Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities
M. Hashimoto (2004)
Lipophilization of Somatostatin Analog RC-160 Improves Its Bioactivity and Stability
P. Dasgupta (2004)
Lipeo-sCT: a novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity.
W. Cheng (2009)
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro‐in vivo evaluation
S. T. Dogru (2000)
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
S. V. R. Rao (2008)
Development and in vivo evaluation of a new oral nanoparticulate dosage form for leuprolide based on polyacrylic acid
J. Iqbal (2011)
Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
P. Bu (2016)
Modifying the release of leuprolide from spray dried OED microparticles.
R. Alcock (2002)
Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique.
M. Trotta (2005)
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle (2005)
Lipid Masking and Reactivation of Angiotensin Analogues
L. Maletínskâ (1996)
Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.
P. Kurtzhals (1995)
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
Juliana de Souza Rebouças (2012)
Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
A. Bernkop-Schnürch (2007)
Crystallographic studies of protein denaturation and renaturation. 2. Sodium dodecyl sulfate induced structural changes in triclinic lysozyme.
A. Yonath (1977)
Water‐soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides
H. Ekrami (1995)
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target.
O. A. Timofeeva (2007)
Development and in vitro evaluation of an oral SEDDS for desmopressin
O. Zupančič (2016)
In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Fabian Hintzen (2014)
Comparison of Pharmacokinetic Parameters of a Polypeptide, the Bowman-Birk Protease Inhibitor (BBI), and Its Palmitic Acid Conjugate
L. Honeycutt (2004)
Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.
Ravi Vaishya (2015)
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
Future directions for peptide therapeutics development.
Allan A. Kaspar (2013)
Strategic Approaches to Optimizing Peptide ADME Properties
Li Di (2014)
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
S. V. R. Rao (2008)
Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres.
S. Choi (2000)
A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species.
S. Prabhu (2001)
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
N. El Tayar (1993)
(D) Routes of delivery: Case studies
P. Smith (1992)
Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.
E. Yodoya (1994)
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
W. Cheng (2008)
Interaction of Alkylsulfonate Ligands with β-Lactoglobulin AB from Bovine Milk
P. Busti (1999)
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.
M. Niu (2014)
Barrier properties of mucus.
Richard A. Cone (2009)
Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.
P. Yue (2010)
Investigation of lectin-modified insulin liposomes as carriers for oral administration.
N. Zhang (2005)
Oral peptide delivery by tetraether lipid liposomes.
J. Parmentier (2011)
Protein-surfactant interactions: a tale of many states.
D. Otzen (2011)
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.
M. Rekha (2013)
Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles.
Rahul S. Kalhapure (2014)
Permeability Characteristics of Tetragastrins Across Intestinal Membranes Using the Caco-2 Monolayer System: Comparison Between Acylation and Application of Protease Inhibitors
T. Fujita (2004)
Coumarinic Acid-Based Cyclic Prodrugs of Opioid Peptides that Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeability
O. S. Gudmundsson (2004)
Acyloxyalkoxy-Based Cyclic Prodrugs of Opioid Peptides: Evaluation of the Chemical and Enzymatic Stability as Well as Their Transport Properties Across Caco-2 Cell Monolayers
A. Bak (2004)
PEG-stearate coated solid lipid nanoparticles as levothyroxine carriers for oral administration
S. Kashanian (2014)
Protective effect of small amounts of sodium dodecyl sulfate on the helical structure of bovine serum albumin in thermal denaturation.
Yoshiko Moriyama (2003)
A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.
A. Lalatsa (2012)
The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex.
Q. Zhang (2012)
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
M. Karsdal (2010)
Structure-Activity Relationship of Reversibly Lipidized Peptides: Studies of Fatty Acid-Desmopressin Conjugates
J. Wang (2004)
Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions.
J. Zhang (2015)
Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases.
G. Leonavičiūtė (2016)
Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery.
S. Hauptstein (2015)
Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme
Ripal Gaudana (2013)
Current Concepts in Intestinal Peptide Absorption
G. Fricker (1996)
Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
J. Cort (1975)
Oral vaccine delivery.
G. Russell-Jones (2000)
POLYMER NONIONIC MICELLE COMPLEXATION - FORMATION OF POLY(PROPYLENE OXIDE)-COMPLEXED N-OCTYL THIOGLUCOSIDE MICELLES
J. Brackman (1988)
Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing.
Wei-guo Dai (2007)
Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers.
B. Wang (1999)
Lipid-based nanocarriers for the oral administration of biopharmaceutics.
T. Karamanidou (2016)
Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level.
E. Flagg (1994)
In vitro and in vivo evaluation of a novel oral insulin formulation 1
H Ma (2006)
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
Measurement of lipophilicity by high performance liquid chromatography comparison with calculated lipophilicity values
J. Sabatka (1987)
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
H. Takeuchi (2005)
Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
A. D. Maggiore (2012)
The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process
R. Yang (2011)
Protamine modified metal ion-protein chelate microparticles for sustained release of interferon.
Yanbo Jiang (2011)
Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators
Pernille Nordly (2009)
Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system
H. Hoensch (2002)
Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions
M. Ijaz (2016)
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
Model Solvent Systems for QSAR Part I. Propylene Glycol Dipelargonate (PGDP). A new Standard Solvent for use in Partition Coefficient Determination
D. Leahy (1989)
Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies.
B. Griffin (2011)
Liphophilic complexation of heparin based on bile acid for oral delivery.
D. Lee (2007)
The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin
J. Thongborisute (2006)
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
Reversible lipidization for the oral delivery of salmon calcitonin.
J. Wang (2003)
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
Interactions between charged polypeptides and nonionic surfactants.
H. Sjögren (2005)
Optical and structural properties of copper-oxytocin dications in the gas phase.
L. Joly (2009)
Structural Modification of Proteins and Peptides
A. Mahajan (2014)
Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier
U. Schroeder (1998)
Strategies for improving mucosal drug delivery.
Flavia Laffleur (2013)
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
S. Maher (2009)
Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.
K. Maiti (2007)
Solid Lipid Particles for Oral Delivery of Peptide and Protein Drugs II – The Digestion of Trilaurin Protects Desmopressin from Proteolytic Degradation
P. C. Christophersen (2014)
Trials of lipid modification of peptide hormones for intestinal delivery
S. Muranishi (1992)
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
Synthetic therapeutic peptides: science and market.
P. Vlieghe (2010)
Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Ken Katayama (2003)
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
Reversible Lipidization Prolongs the Pharmacological Effect, Plasma Duration, and Liver Retention of Octreotide
Liyun Yuan (2004)
Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.
H. Asada (1995)
Non-Ionic Surfactant Vesicles (Niosomes) as New Drug Delivery Systems
A. Pardakhty (2017)
This paper is referenced by
Self‐emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release
Imran Nazir (2019)
Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs
S. Bonengel (2018)
Surface phosphorylation of nanoparticles by hexokinase: A powerful tool for cellular uptake improvement.
Imran Nazir (2018)
Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients.
G. Hetényi (2018)
Advances in the Study of Marine Products with Lipid-Lowering Properties
J. Zhao (2020)
Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
Thị Như Quỳnh Phan (2019)
Preventive effect of goby fish protein hydrolysates on hyperlipidemia and cardiovascular disease in Wistar rats fed a high-fat/fructose diet
R. Nasri (2018)
Self- emulsifying drug delivery systems (SEDDS): new hope in the heart of orally delivered macromolecules
Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.
Joanne Heade (2018)
Storage stability of proteins in a liquid-based formulation: liquid vs. solid self-emulsifying drug delivery.
Haniyeh Etezadi (2020)
Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update
S. Maher (2019)
Intestinal permeation enhancers to improve oral bioavailability of macromolecules: Reasons for low efficacy in humans.
S. Maher (2020)
Development and in vitro evaluation of a self‐emulsifying drug delivery system (SEDDS) for oral vancomycin administration
S. Zaichik (2019)
A Polymer Chemistry Point of View on Mucoadhesion and Mucopenetration.
Philipp S. Schattling (2017)
Effect of surface hydrophobicity of therapeutic protein loaded in polyelectrolyte nanoparticles on transepithelial permeability
Ana Miklavžin (2018)
In vivo evaluation of an oral self‐emulsifying drug delivery system (SEDDS) for exenatide
Claudia Menzel (2018)
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Laura Bayón-Cordero (2019)
Hydrophobic H-bond pairing: A novel approach to improve membrane permeability.
Imran Nazir (2019)
Methods for engineering therapeutic peptides
Yaohao Li (2018)
Peptides as drug delivery vehicles across biological barriers
D. Ghosh (2017)
Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Thị Như Quỳnh Phan (2019)
Lipid-based nanosuspensions for oral delivery of peptides, a critical review.
Camille Dumont (2018)